Although only a limited number of studies have looked at the impact of adjuvant chemotherapy and/or aromatase inhibitors on glucose and insulin metabolism in women with BC, it appears that a negative effect is the most common observation. The gene discussed is CYP19A1; the disease is breast cancer.